A carregar...

Predictive Biomarkers of Antiangiogenic Therapy for Advanced Hepatocellular Carcinoma: Where Are We?

Antiangiogenic therapy, especially treatment with sorafenib, is the primary treatment for patients with advanced hepatocellular carcinoma (HCC). However, the efficacy of such therapy is modest, with low objective response rates and limited prolongation of survival times. Several researchers have inv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Shao, Yu-Yun, Hsu, Chih-Hung, Cheng, Ann-Lii
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3740718/
https://ncbi.nlm.nih.gov/pubmed/24159601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000343845
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!